Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2019 08:30 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. to Present at the 31st Annual ROTH Conference

SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive...
March 18, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA

SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the publication of clinical findings for...
March 11, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience receives notification of second award from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development for the development of Ovaprene®

SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it received a second Notice of Award of $982,851, part...
March 05, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. to Present at the Cowen 39th Annual Healthcare Conference

SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive...
February 28, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. to Present at the 16th Annual BIO Asia International Conference

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer,...
February 05, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. to Present at the 2019 BIO CEO & Investor Conference

SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer,...
January 02, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Provides Update for Investors on Development Programs and Anticipated 2019 Milestones

Key anticipated 2019 clinical milestones: Topline results of Ovaprene® PCT clinical trialInitiation of at-home portion of Sildenafil Cream, 3.6% Phase 2b Initiation of pivotal Phase 3 study of...
December 06, 2018 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today announced that it has entered into definitive...
November 29, 2018 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Announces Initiation of Content Validity Study for Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder

SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in clinical-stage women’s health innovation, and Strategic Science & Technologies, LLC (SST), a...
November 27, 2018 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Announces Enrollment in Thermography Feasibility Study with Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder

SAN DIEGO, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today announced that it is currently enrolling patients in an...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right